Literature DB >> 26079770

Implications of proposed fibromyalgia criteria across other functional pain syndromes.

N Egloff1,2, R von Känel3,4, V Müller1, U T Egle5, G Kokinogenis1,2, S Lederbogen1, B Durrer1, S Stauber1.   

Abstract

OBJECTIVES: In 2010, the American College of Rheumatology (ACR) proposed new criteria for the diagnosis of fibromyalgia (FM) in the context of objections to components of the criteria of 1990. The new criteria consider the Widespread Pain Index (WPI) and the Symptom Severity Score (SSS). This study evaluated the implications of the new diagnostic criteria for FM across other functional pain syndromes.
METHOD: A cohort of 300 consecutive in-patients with functional pain syndromes underwent a diagnostic screen according to the ACR 2010 criteria. Additionally, systematic pain assessment including algometric and psychometric data was carried out.
RESULTS: Twenty-five patients (8.3%) had been diagnosed with FM according to the ACR 1990 criteria. Twenty-one of them (84%) also met the new ACR 2010 criteria. In total, 130 patients (43%) fulfilled the new ACR 2010 criteria. A comparison of new vs. old cases showed a high degree of conformity in most of the pain characteristics. The new FM cases, however, revealed a pronounced heterogeneity in the anatomical pain locations, including several types of localized pain syndromes. Furthermore, patients fulfilling the ACR 2010 FM criteria differed from those with other functional pain syndromes; they had increased pain sensitivity scores and increased psychometric values for depression, anxiety, and psychological distress (p<0.01).
CONCLUSIONS: FM according to the ACR 2010 criteria describes the 'severe half' of the spectrum of functional pain syndromes. By dropping the requirement of 'generalized pain', these criteria result in a blurring of the distinction between FM and more localized functional pain syndromes.

Entities:  

Mesh:

Year:  2015        PMID: 26079770     DOI: 10.3109/03009742.2015.1010103

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

1.  Performance of the American College of Rheumatology 2016 criteria for fibromyalgia in a referral care setting.

Authors:  Sakir Ahmed; Amita Aggarwal; Able Lawrence
Journal:  Rheumatol Int       Date:  2019-05-17       Impact factor: 2.631

2.  The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology.

Authors:  Bontle G Malatji; Shayne Mason; Lodewyk J Mienie; Ron A Wevers; Helgard Meyer; Mari van Reenen; Carolus J Reinecke
Journal:  Metabolomics       Date:  2019-03-27       Impact factor: 4.290

Review 3.  Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia.

Authors:  Ali Bidari; Banafsheh Ghavidel-Parsa
Journal:  Clin Rheumatol       Date:  2022-06-14       Impact factor: 3.650

4.  Fibromyalgia diagnostic model derived from combination of American College of Rheumatology 1990 and 2011 criteria.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Asghar Hajiabbasi; Irandokht Shenavar; Babak Ghalehbaghi; Omid Sanaei
Journal:  Korean J Pain       Date:  2019-04-01

5.  Impact of a specific training programme on the neuromodulation of pain in female patient with fibromyalgia (DouFiSport): a 24-month, controlled, randomised, double-blind protocol.

Authors:  Anais Le Fur Bonnabesse; Mathilde Cabon; Gildas L'Heveder; Aurélie Kermarrec; Bertrand Quinio; Alain Woda; Serge Marchand; Amandine Dubois; Marie-Agnes Giroux-Metges; Fabrice Rannou; Laurent Misery; Céline Bodéré
Journal:  BMJ Open       Date:  2019-01-25       Impact factor: 2.692

Review 6.  The Evolution of Fibromyalgia, Its Concepts, and Criteria.

Authors:  Frederick Wolfe; Johannes J Rasker
Journal:  Cureus       Date:  2021-11-29

7.  Implication of the Nociplastic Features for Clinical Diagnosis of Fibromyalgia: Development of the Preliminary Nociplastic-Based Fibromyalgia Features (NFF) Tool.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Zahra Atrkarroushan; Mohammad-Javad Khosousi
Journal:  ACR Open Rheumatol       Date:  2021-12-22

Review 8.  Challenges in fibromyalgia diagnosis: from meaning of symptoms to fibromyalgia labeling.

Authors:  Ali Bidari; Banafsheh Ghavidel Parsa; Babak Ghalehbaghi
Journal:  Korean J Pain       Date:  2018-07-02

9.  Rethinking the criteria for fibromyalgia in 2019: the ABC indicators.

Authors:  Julian A Stewart; Simone Mailler-Burch; Darius Müller; Martina Studer; Roland von Känel; Martin Grosse Holtforth; Kyrill Schwegler; Niklaus Egloff
Journal:  J Pain Res       Date:  2019-07-10       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.